Skip to main content
Sinphar Pharmaceutical Co., Ltd. logo

Sinphar Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,597 across all filing types
Latest filing 2026-05-11 Regulatory Filings
Country TW Taiwan
Listing TW 1734

About Sinphar Pharmaceutical Co., Ltd.

https://www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
115年4月背書保證與資金貸與
Regulatory Filings Classification · 40% confidence The document is a periodic disclosure of the company’s fund lending and guarantee balances provided under Taiwan’s Market Observation Post System (“公開資訊觀測站”). It contains tabular data on loan and guarantee exposures for the current and prior months. It is not a comprehensive financial report (e.g., interim report) nor an announcement of a report’s publication. It is a general regulatory submission required by the exchange, so it falls under the Regulatory Filings category.
2026-05-11 Chinese
115年4月營業收入
Regulatory Filings Classification · 10% confidence The provided text is clearly not a corporate filing but an error page stating the page cannot be accessed. It contains no references to any report, financial data, announcements, or regulatory content. By the fallback rule for documents that do not fit any specific category, it is classified as a general regulatory/other filing (RNS).
2026-05-11 Chinese
公告本公司115年第一季合併財務報告 董事會召開日期為115年05月05日
Report Publication Announcement Classification · 90% confidence The document is a brief announcement via Taiwan’s Market Observation Post System (公開資訊觀測站) stating the board meeting date and that the company will present its 115-year first quarter consolidated financial report. It does not include the financial data itself but merely notifies stakeholders of the upcoming report and meeting. This matches the definition of a Report Publication Announcement (RPA).
2026-04-27 Chinese
115年3月背書保證與資金貸與
Regulatory Filings Classification · 80% confidence The document is a routine regulatory disclosure from a Taiwanese listed company (“公開資訊觀測站”＝Market Observation Post System) detailing its fund lending and endorsement/guarantee balances. It is not a full financial report, earnings release, capital change notice, or management presentation. It is a standard regulatory filing that does not fit other specific categories, so it falls under the fallback “Regulatory Filings (RNS).”
2026-04-10 Chinese
115年3月營業收入
Regulatory Filings Classification · 82% confidence The document is a monthly revenue summary report filed on MOPS for the listed company 杏輝, showing net operating revenue figures for the current month and year-to-date with YoY comparisons. It is neither a full interim/quarterly report nor an earnings release (which covers quarterly results), but a regulatory data disclosure under Taiwan’s MOPS system without any accompanying narrative or management discussion. No specialized category fits this minimal financial data table, so it falls under the fallback “Regulatory Filings” category (RNS).
2026-04-10 Chinese
115年03月內部人持股異動(事後)
Director's Dealing Classification · 90% confidence The document is a detailed, month-by-month insider shareholding disclosure listing directors, senior management, and their family members’ holdings, along with any increases or decreases this month. This corresponds to insider transaction reporting (director’s dealings) rather than a broader financial report or a simple announcement. Therefore, it should be classified as a Director’s Dealing filing.
2026-04-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.